Pacira BioSciences' Cash & Current Investments fell 4571.87% to $246.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.3 million, marking a year-over-year decrease of 4571.87%. This contributed to the annual value of $484.6 million for FY2024, which is 7395.84% up from last year.
As of Q3 2025, Pacira BioSciences' Cash & Current Investments stood at $246.3 million, which was down 4571.87% from $445.9 million recorded in Q2 2025.
Pacira BioSciences' 5-year Cash & Current Investments high stood at $693.9 million for Q3 2021, and its period low was $174.0 million during Q1 2023.
Its 5-year average for Cash & Current Investments is $407.1 million, with a median of $404.2 million in 2024.
Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 9786.13% in 2021, then crashed by 6152.12% in 2023.
Quarter analysis of 5 years shows Pacira BioSciences' Cash & Current Investments stood at $656.4 million in 2021, then plummeted by 56.03% to $288.7 million in 2022, then dropped by 3.49% to $278.6 million in 2023, then surged by 73.96% to $484.6 million in 2024, then crashed by 49.17% to $246.3 million in 2025.
Its Cash & Current Investments stands at $246.3 million for Q3 2025, versus $445.9 million for Q2 2025 and $493.6 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value